Skip to content

Comparison of clinical and radiographic success rates of Pulpotomy in primary molars using formocresol, Portland cement and NeoMTA Plus: a double-blind randomized clinical trial

Comparison of clinical and radiographic success rates of Pulpotomy in primary molars using formocresol, Portland cement and NeoMTA Plus: a double-blind randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180521039763N5
Enrollment
96
Registered
2022-03-14
Start date
2022-02-24
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulpitis. Pulpitis

Interventions

Intervention 1: Control group: Cotton pellet impregnated with formocresol (sultan, USA) is placed on the pulp for 5 minutes. Intervention 2: Intervention group: 1: After pulp tissue homeostasis, Portl
SãoPaulo, SP, Brazil) is mixed according to the manufacturer's instructions and placed in thepulp chamber. 2: After pulp tissue homeostasis, NeoMTA Plus material (Avalon Biomed Inc. (Bradenton, FL, US

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 9 Years

Inclusion criteria

Inclusion criteria: Pulp exposure due to caries No pathologic mobility No pain in percussion No history of night pain No sinus tracts, abscess or swelling Restorable teeth with ssc Hemostasis could be easily achievable No internal or pathologic external root resorption No interradicular or periapical radiolucency and Periodontal ligament widening

Exclusion criteria

Exclusion criteria: Existence of any systemic disease such as leukemia that the child can not be treated with pulp therapy internal or pathologic external root resorption Periodontal ligament widening interradicular or periapical radiolucency If more than two thirds of the root length has undergone physiological resorption Blockage of the pulp canals

Design outcomes

Primary

MeasureTime frame
Mutation and cytogenetic formocresol. Timepoint: 12 month later. Method of measurement: Through clinical and radiographic evaluation and questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPouya Karimipour Fard

Kerman University of Medical Sciences

pouyakm1996@gmail.com+98 34 3211 9021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026